{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:47:13Z","timestamp":1783086433500,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Women and Children\u2019s Medical Center Clinical Doctor Initiation Scientific Research Fund","award":["2023BS008"],"award-info":[{"award-number":["2023BS008"]}]},{"name":"Science and Technology Program of Guangzhou","award":["202102010222"],"award-info":[{"award-number":["202102010222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01663-2","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T05:08:32Z","timestamp":1747544912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel mouse model for X-linked Alport syndrome induced by splicing mutation in the Col4a5 gene"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhitao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"key":"1663_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","volume":"70","author":"M Gubler","year":"1981","unstructured":"Gubler, M. et al. Alport\u2019s syndrome. A report of 58 cases and a review of the literature. Am. J. Med. 70, 493\u2013505. https:\/\/doi.org\/10.1016\/0002-9343(81)90571-4 (1981).","journal-title":"Am. J. Med."},{"key":"1663_CR2","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson, J. et al. Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J. Am. Soc. Nephrol. 32, 2273\u20132290. https:\/\/doi.org\/10.1681\/ASN.2020071065 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR3","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.2174\/0929867328666210108113500","volume":"28","author":"AL Pedrosa","year":"2021","unstructured":"Pedrosa, A. L. et al. Alport syndrome: A comprehensive review on genetics, pathophysiology, histology, clinical and therapeutic perspectives. Curr. Med. Chem. 28, 5602\u20135624. https:\/\/doi.org\/10.2174\/0929867328666210108113500 (2021).","journal-title":"Curr. Med. Chem."},{"key":"1663_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross, O. et al. Early angiotensin-converting enzyme Inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int. 81, 494\u2013501. https:\/\/doi.org\/10.1038\/ki.2011.407 (2012).","journal-title":"Kidney Int."},{"key":"1663_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan, C. E. & Gross, O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr. Nephrol. 36, 711\u2013719. https:\/\/doi.org\/10.1007\/s00467-020-04819-6 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1663_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1985.63","volume":"27","author":"J Feingold","year":"1985","unstructured":"Feingold, J. et al. Genetic heterogeneity of Alport syndrome. Kidney Int. 27, 672\u2013677. https:\/\/doi.org\/10.1038\/ki.1985.63 (1985).","journal-title":"Kidney Int."},{"key":"1663_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.2349482","volume":"248","author":"DF Barker","year":"1990","unstructured":"Barker, D. F. et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248, 1224\u20131227. https:\/\/doi.org\/10.1126\/science.2349482 (1990).","journal-title":"Science"},{"key":"1663_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan, C. E. Alport syndrome: achieving early diagnosis and treatment. Am. J. Kidney Dis. 77, 272\u2013279. https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.026 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"1663_CR9","doi-asserted-by":"publisher","unstructured":"Nikolaou, S. & Deltas, C. A. Comparative presentation of mouse models that recapitulate most features of Alport syndrome. Genes (Basel). 13. https:\/\/doi.org\/10.3390\/genes13101893 (2022).","DOI":"10.3390\/genes13101893"},{"key":"1663_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrep.2018.12.003","volume":"17","author":"K Hashikami","year":"2019","unstructured":"Hashikami, K. et al. Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation. Biochem. Biophys. Rep. 17, 81\u201386. https:\/\/doi.org\/10.1016\/j.bbrep.2018.12.003 (2019).","journal-title":"Biochem. Biophys. Rep."},{"key":"1663_CR11","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/01.asn.0000130562.90255.8f","volume":"15","author":"MN Rheault","year":"2004","unstructured":"Rheault, M. N. et al. Mouse model of X-linked Alport syndrome. J. Am. Soc. Nephrol. 15, 1466\u20131474. https:\/\/doi.org\/10.1097\/01.asn.0000130562.90255.8f (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR12","doi-asserted-by":"publisher","first-page":"1086756","DOI":"10.3389\/fmed.2023.1086756","volume":"10","author":"WQ Wu","year":"2023","unstructured":"Wu, W. Q. et al. A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene. Front. Med. (Lausanne). 10, 1086756. https:\/\/doi.org\/10.3389\/fmed.2023.1086756 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"1663_CR13","first-page":"649","volume":"25","author":"Z Tang","year":"2008","unstructured":"Tang, Z. et al. [A novel COL4A5 splicing mutation causing Alport syndrome in a Chinese family]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 25, 649\u2013652 (2008).","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"1663_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"1663_CR15","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/ndt\/gfab334","volume":"37","author":"A Mastrangelo","year":"2022","unstructured":"Mastrangelo, A., Madeira, C., Castorina, P., Giani, M. & Montini, G. Heterozygous COL4A3\/COL4A4 mutations: the hidden part of the iceberg? Nephrol. Dial Transpl. 37, 2398\u20132407. https:\/\/doi.org\/10.1093\/ndt\/gfab334 (2022).","journal-title":"Nephrol. Dial Transpl."},{"key":"1663_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cge.12919","volume":"92","author":"C Fallerini","year":"2017","unstructured":"Fallerini, C. et al. Alport syndrome: impact of digenic inheritance in patients management. Clin. Genet. 92, 34\u201344. https:\/\/doi.org\/10.1111\/cge.12919 (2017).","journal-title":"Clin. Genet."},{"key":"1663_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige, J. et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur. J. Hum. Genet. 29, 1186\u20131197. https:\/\/doi.org\/10.1038\/s41431-021-00858-1 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"1663_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.kint.2017.05.017","volume":"92","author":"F Ding","year":"2017","unstructured":"Ding, F. et al. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport syndrome. Kidney Int. 92, 1515\u20131525. https:\/\/doi.org\/10.1016\/j.kint.2017.05.017 (2017).","journal-title":"Kidney Int."},{"key":"1663_CR19","doi-asserted-by":"publisher","unstructured":"Gyarmati, G. et al. Intravital imaging reveals glomerular capillary distension and endothelial and immune cell activation early in Alport syndrome. JCI Insight. 7 https:\/\/doi.org\/10.1172\/jci.insight.152676 (2022).","DOI":"10.1172\/jci.insight.152676"},{"key":"1663_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ki.2010.373","volume":"79","author":"M Ryu","year":"2011","unstructured":"Ryu, M. et al. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-alpha-mediated podocyte loss. Kidney Int. 79, 189\u2013198. https:\/\/doi.org\/10.1038\/ki.2010.373 (2011).","journal-title":"Kidney Int."},{"key":"1663_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2215\/CJN.10581014","volume":"10","author":"J Savige","year":"2015","unstructured":"Savige, J. et al. Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin. J. Am. Soc. Nephrol. 10, 703\u2013709. https:\/\/doi.org\/10.2215\/CJN.10581014 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1663_CR22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia, M. R. et al. Genotype-phenotype correlation in X-linked Alport syndrome. J. Am. Soc. Nephrol. 21, 876\u2013883. https:\/\/doi.org\/10.1681\/ASN.2009070784 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR23","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl. J. Med. 348, 2543\u20132556. https:\/\/doi.org\/10.1056\/NEJMra022296 (2003).","journal-title":"N Engl. J. Med."},{"key":"1663_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J. Am. Soc. Nephrol. 11, 649\u2013657. https:\/\/doi.org\/10.1681\/ASN.V114649 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR25","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.asn.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a European community Alport syndrome concerted action study. J. Am. Soc. Nephrol. 14, 2603\u20132610. https:\/\/doi.org\/10.1097\/01.asn.0000090034.71205.74 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2008090984","volume":"20","author":"L Heidet","year":"2009","unstructured":"Heidet, L. & Gubler, M. C. The renal lesions of Alport syndrome. J. Am. Soc. Nephrol. 20, 1210\u20131215. https:\/\/doi.org\/10.1681\/ASN.2008090984 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1681\/ASN.2021040577","volume":"33","author":"AA Widjaja","year":"2022","unstructured":"Widjaja, A. A. et al. A neutralizing IL-11 antibody improves renal function and increases lifespan in a mouse model of Alport syndrome. J. Am. Soc. Nephrol. 33, 718\u2013730. https:\/\/doi.org\/10.1681\/ASN.2021040577 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01706-8","author":"S Daga","year":"2024","unstructured":"Daga, S. et al. Slowly progressive autosomal dominant Alport syndrome due to COL4A3 splicing variant. Eur. J. Hum. Genet. https:\/\/doi.org\/10.1038\/s41431-024-01706-8 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"1663_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/nep.13115","volume":"23","author":"A Imafuku","year":"2018","unstructured":"Imafuku, A. et al. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically. Nephrol. (Carlton). 23, 940\u2013947. https:\/\/doi.org\/10.1111\/nep.13115 (2018).","journal-title":"Nephrol. (Carlton)"},{"key":"1663_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.matbio.2016.08.005","volume":"57\u201358","author":"D Cosgrove","year":"2017","unstructured":"Cosgrove, D., Liu, S. & Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. Matrix Biol. 57\u201358, 45\u201354. https:\/\/doi.org\/10.1016\/j.matbio.2016.08.005 (2017).","journal-title":"Matrix Biol."},{"key":"1663_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.kint.2021.08.026","volume":"101","author":"CN Frank","year":"2022","unstructured":"Frank, C. N. et al. Effect of disease progression on the podocyte cell cycle in Alport syndrome. Kidney Int. 101, 106\u2013118. https:\/\/doi.org\/10.1016\/j.kint.2021.08.026 (2022).","journal-title":"Kidney Int."},{"key":"1663_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1681\/ASN.2014111109","volume":"27","author":"R Fukuda","year":"2016","unstructured":"Fukuda, R. et al. Podocyte p53 limits the severity of experimental Alport syndrome. J. Am. Soc. Nephrol. 27, 144\u2013157. https:\/\/doi.org\/10.1681\/ASN.2014111109 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.humpath.2009.08.024","volume":"41","author":"J Jedlicka","year":"2010","unstructured":"Jedlicka, J. et al. Interstitial inflammation in Alport syndrome. Hum. Pathol. 41, 582\u2013593. https:\/\/doi.org\/10.1016\/j.humpath.2009.08.024 (2010).","journal-title":"Hum. Pathol."},{"key":"1663_CR34","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1681\/ASN.2005101044","volume":"17","author":"B Beirowski","year":"2006","unstructured":"Beirowski, B., Weber, M. & Gross, O. Chronic renal failure and shortened lifespan in COL4A3+\/- mice: an animal model for thin basement membrane nephropathy. J. Am. Soc. Nephrol. 17, 1986\u20131994. https:\/\/doi.org\/10.1681\/ASN.2005101044 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1663_CR35","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41467-020-16605-x","volume":"11","author":"T Yamamura","year":"2020","unstructured":"Yamamura, T. et al. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5. Nat. Commun. 11, 2777. https:\/\/doi.org\/10.1038\/s41467-020-16605-x (2020).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01663-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T05:08:32Z","timestamp":1747544912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01663-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01663-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17236"}}